The store will not work correctly when cookies are disabled.
N-(4-hydroxy-3-methylphenyl)-3-nitrobenzamide
ID: ALA4093115
PubChem CID: 3566355
Max Phase: Preclinical
Molecular Formula: C14H12N2O4
Molecular Weight: 272.26
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(NC(=O)c2cccc([N+](=O)[O-])c2)ccc1O
Standard InChI: InChI=1S/C14H12N2O4/c1-9-7-11(5-6-13(9)17)15-14(18)10-3-2-4-12(8-10)16(19)20/h2-8,17H,1H3,(H,15,18)
Standard InChI Key: DPGCGCDYLIBFMT-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
4.5014 -1.9893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5002 -2.8088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2083 -3.2178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9180 -2.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9151 -1.9857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2065 -1.5804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6263 -3.2158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6276 -4.0330 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3334 -2.8061 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0417 -3.2136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0384 -4.0293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7459 -4.4367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4539 -4.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4500 -3.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7419 -2.8018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7922 -3.2169 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0848 -2.8077 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7916 -4.0340 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1556 -2.7933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1628 -4.4334 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
2 16 1 0
16 17 1 0
16 18 2 0
14 19 1 0
13 20 1 0
M CHG 2 16 1 17 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 272.26 | Molecular Weight (Monoisotopic): 272.0797 | AlogP: 2.86 | #Rotatable Bonds: 3 |
Polar Surface Area: 92.47 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.80 | CX Basic pKa: ┄ | CX LogP: 3.21 | CX LogD: 3.21 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.51 | Np Likeness Score: -1.51 |
References
1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH.. (2017) Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms., 27 (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063] |